{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:01:33Z","timestamp":1790233293732,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.jneuroim.2006.05.011","type":"journal-article","created":{"date-parts":[[2006,7,4]],"date-time":"2006-07-04T11:12:31Z","timestamp":1152011551000},"page":"215-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Antimicrobial activity of Substance P and Neuropeptide Y against laboratory strains of bacteria and oral microorganisms"],"prefix":"10.1016","volume":"177","author":[{"given":"Christopher J.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kindra K.","family":"Burnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Brogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2006.05.011_bib1","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/JCM.43.11.5721-5732.2005","article-title":"Defining the normal bacterial flora of the oral cavity","volume":"43","author":"Aas","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1034\/j.1600-0447.2002.21236.x","article-title":"Quantitative analysis of substance P, neurokinin A and calcitonin gene-related peptide in gingival crevicular fluid associated with painful human teeth","volume":"110","author":"Awawdeh","year":"2002","journal-title":"Eur. J. Oral. Sci."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2004.04.006","article-title":"Neuropeptide Y and epilepsy: recent progress, prospects and controversies","volume":"38","author":"Baraban","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jneuroim.2006.05.011_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(02)00424-1","article-title":"Relevance of neuropeptide Y for the neuroimmune crosstalk","volume":"134","author":"Bedoui","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0528.2005.00232.x","article-title":"The complex oral microflora of high-risk individuals and groups and its role in the caries process","volume":"33","author":"Beighton","year":"2005","journal-title":"Community Dent. Oral Epidemiol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.45.1.331-334.2001","article-title":"The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection","volume":"45","author":"Brogden","year":"2001","journal-title":"Antimicrob. Agents Chem."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ni1209","article-title":"The nervous system and innate immunity: the neuropeptide connection","volume":"6","author":"Brogden","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: antimicrobial peptides of innate immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib10","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1128\/AAC.45.11.3216-3219.2001","article-title":"Susceptibilities of oral bacteria and yeast to mammalian cathelicidins","volume":"45","author":"Guthmiller","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jneuroim.2006.05.011_bib12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0028-3908(00)00010-1","article-title":"Neuropeptides \u2014 an overview","volume":"39","author":"Hokfelt","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneuroim.2006.05.011_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/JCM.42.3.1024-1029.2004","article-title":"Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms","volume":"42","author":"Joly","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib14","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/AAC.45.11.3256-3261.2001","article-title":"Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells","volume":"45","author":"Kalfa","year":"2001","journal-title":"Antimicrob. Agents Chem."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0196-9781(03)00129-3","article-title":"Leukocyte motility in response to neuropeptides is heparan sulfate proteoglycan dependent","volume":"24","author":"Kaneider","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.jneuroim.2006.05.011_bib16","doi-asserted-by":"crossref","first-page":"79S","DOI":"10.1111\/j.1365-2672.1993.tb04344.x","article-title":"Coaggregation of human oral bacteria: potential role in the accretion of dental plaque","volume":"74","author":"Kolenbrander","year":"1993","journal-title":"J. Appl. Bacteriol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0024-3205(02)01740-X","article-title":"Direct antimicrobial properties of substance P","volume":"71","author":"Kowalska","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib18","series-title":"The British Society for Dental Research Annual Scientific Meeting, Birmingham, United Kingdom","article-title":"Neuropeptide Y in GCF in periodontal health and disease","author":"Linden","year":"2004"},{"key":"10.1016\/j.jneuroim.2006.05.011_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/154411130401500203","article-title":"Neuropeptides and neurogenic mechanisms in oral and periodontal inflammation","volume":"15","author":"Lundy","year":"2004","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-0115(00)00134-8","article-title":"The NPY effects on murine leukocyte adherence and chemotaxis change with age. Adherent cell implication","volume":"95","author":"Medina","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2334\/josnusd.47.59","article-title":"Transmission, diversity and virulence factors of Streptococcus mutans genotypes","volume":"47","author":"Napimoga","year":"2005","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1902\/annals.1996.1.1.821","article-title":"Periodontal diseases: pathogenesis","volume":"1","author":"Offenbacher","year":"1996","journal-title":"Ann. Periodontol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib23","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.4049\/jimmunol.176.6.3788","article-title":"Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities","volume":"176","author":"Pang","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib24","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/AAC.42.10.2745","article-title":"Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation","volume":"42","author":"Shimizu","year":"1998","journal-title":"Antimicrob. Agents Chem."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib25","first-page":"169","article-title":"Designer assays for antimicrobial peptides. Disputing the \u201cone-size-fits-all\u2019\u2019 theory","volume":"78","author":"Steinberg","year":"1997","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/154405910608500407","article-title":"Subgingival and tongue microbiota during early periodontitis","volume":"85","author":"Tanner","year":"2006","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib27","series-title":"Antimicrobial Sequences Database","author":"Tossi","year":"2005"},{"key":"10.1016\/j.jneuroim.2006.05.011_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/1096-9861(20000717)423:1<13::AID-CNE2>3.0.CO;2-P","article-title":"Expression of neuropeptide Y in olfactory ensheathing cells during prenatal development","volume":"423","author":"Ubink","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tins.2003.09.003","article-title":"'Neuro'-peptides in glia: focus on NPY and galanin","volume":"26","author":"Ubink","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-2236(98)01284-3","article-title":"Neuropeptide Y: emerging evidence for a functional role in seizure modulation","volume":"22","author":"Vezzani","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0165-6147(02)02105-3","article-title":"Antimicrobial peptides from animals: focus on invertebrates","volume":"23","author":"Vizioli","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2006.05.011_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806001986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806001986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:04:04Z","timestamp":1759046644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572806001986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0165572806001986"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.05.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial activity of Substance P and Neuropeptide Y against laboratory strains of bacteria and oral microorganisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}